Navigation Links
Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy
Date:12/8/2009

ndergo chemotherapy. The aim is to kill off the cancer cells.

Even if the chemotherapy appears to be successful, the disease soon recurs in a high number of patients. In certain cases, therefore, it is recommended that high-dose chemotherapy and autologous stem cell transplantation is followed immediately. Autologous stem cell transplantation is a planned rescue therapy for high-dose chemotherapy-related severe haematological toxicity. The increased dose is intended to reach those hidden cancer cells that may have hitherto survived - at least this is the assumption of this experimental procedure. However, the cancer cells may be resistant to the chemotherapy, irrespective of the size of the dose.

Autologous stem cell transplantation: stem cells are donated by patients

This type of high-dose chemotherapy usually damages vital haematopoietic stem cells in addition to the tumour cells. Consequently, stem cells are removed from the patient before the treatment and re-implanted afterwards. These stem cells mostly colonize the bone marrow and stimulate haematopoiesis. If the transferred stem cells originate from the patient, this is known as autologous stem cell transplantation. IQWiG did not investigate allogenic stem cell transplantation, where the cells are donated by a donor.

IQWiG investigates benefit for high-risk patients

The focus of this report published by IQWiG is on "high-risk patients": these are patients who have an advanced localized or metastasized soft tissue sarcoma. In order to assess the benefit of autologous stem cell transplantation, IQWiG and its external experts compared the treatment results of patients with and without stem cell transplantation as presented in the scientific literature currently available.

Studies without a control group were also included

As with the disease itself, stem cell transplantation for soft tissue sarcomas is relatively rare. In 2005,
'/>"/>

Contact: Dr. Anna-Sabine Ernst
info@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com : Supports first randomized, placebo-controlled clinical trial in the U.S. using autologous adult stem cells to treat patients with end-stage Critical Limb Ischemia
2. Reportlinker Adds Organ and Tissue Transplantation - A World Market Analysis
3. African Americans Fare Worse After Undergoing Liver Transplantation Due to Hepatitis C
4. Women Are at Greater Risk Than Men of Graft Loss After Undergoing Liver Transplantation for Hepatitis C-related Liver Disease
5. Important new novel 2009 H1N1 flu advisory for cardiopulmonary transplantation
6. Recent Developments in Transplantation Headline AST Meeting
7. Women, blacks, Medicare recipients less likely to be evaluated for liver transplantation
8. Racial disparity studied in patients undergoing liver transplantation for hepatitis B
9. Study examines liver transplantation after drug induced acute liver failure
10. Cell transplantation and cardiac repair
11. Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Gabe’s Chemo Duck Program ... App, the first app ever created for kids with cancer. The ... phones and devices, is filled with enjoyable games to help children ... treatments. The free app helps to keep kids entertained, educated and ...
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... pharmaceuticals in water, LISLE, Ill., May 8 ... are not strict,enough, according to a scientific opinion poll ... results follows a survey in March,that showed more than ... The U.S. Senate has begun public hearings,to look into ...
... MPR ) announced today that it expects to issue ... on Thursday, May 22, 2008. Raymond,J. De Hont, Chairman ... President of Finance and Chief Financial Officer, will hold ... 11:00 AM (Eastern).,Met-Pro,s earnings release and the accompanying financial ...
... Optimize Reconstruction Surgery, TORONTO, May 8 /PRNewswire-FirstCall/ ... real-time imaging and image guidance systems for,use in ... at Duke,University Hospital in Durham, North Carolina are ... surgical procedures. Since,beginning to use SPY near the ...
... Cover MLS Events;, Launches User-Generated Video Contest, Winning Entries to be ... ... YORK and LOS ANGELES, May 8 Juniper,Content Corporation,s (OTC Bulletin Board: ... Como un MLS Pro" (translated "Play Like an MLS Pro") seven-month,joint initiative ...
... most likely too conservative , , THURSDAY, May 8 (HealthDay ... billion a year in lost earnings alone, a new report ... that greatly limit a person,s ability to function for at ... linked to suicidal behaviors or frequent violent acts, as serious ...
... Qualifications Panel, NEW HAVEN, Conn., May 8 ... it had received a letter, dated,May 7, 2008, from ... common stock will be delisted from the Nasdaq Capital ... 2008 because the Company does not,comply with Marketplace Rule ...
Cached Medicine News:Health News:Half of Americans Want Stricter Water Quality Laws, Survey Finds 2Health News:Met-Pro Corporation to Report First Quarter Earnings on May 22 2Health News:Met-Pro Corporation to Report First Quarter Earnings on May 22 3Health News:Leading Plastic Surgeons at Duke Adopt SPY 2Health News:Leading Plastic Surgeons at Duke Adopt SPY 3Health News:Leading Plastic Surgeons at Duke Adopt SPY 4Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 2Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 3Health News:Sorpresa! and Major League Soccer Kick Off Partnership With Interactive Online Contests for Young Soccer Fans 4Health News:Mental Illness Costs U.S. Billions in Lost Earnings 2Health News:Vion Pharmaceuticals to Appeal Nasdaq Delisting 2Health News:Vion Pharmaceuticals to Appeal Nasdaq Delisting 3
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)... Idaho , Jan. 23, 2015  Now available for ... No. 7,849,611) support that prevents ankle sprains by cushioning ... brace, it fits securely around the outside of any ... mobility & comfort while still offering protection against sprains. ...
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ... ("CBAI" or the "Company")  filed a Preliminary Proxy Statement, Schedule ... ) today, and provides an update for shareholders detailing why ... is requested. Dear Shareholders, As we ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4
... April 09, 2007 /PRNewswire-FirstCall/ --,Telik, Inc. announced ... 2 trial of the triplet combination of ... be,presented at the 98th annual meeting of ... Los Angeles. Preclinical studies of,cellular and molecular ...
... BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Apr 11, 2007 - ... that scientists from the company will present ... seliciclib, the company's,most advanced drug candidates in ... two poster presentations during the upcoming,Annual Meeting ...
Cached Medicine Technology:Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 2Telik Announces Telcyta Clinical and Preclinical Presentations at,AACR Meeting 3Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 2Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 3Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR 4
... Neurocare is a full-featured physiologic testing system offered ... contains many of the features of our flagship ... economical price. , ,The smaller size of the ... environment, the physician's office, a mobile service or ...
The CD Horizon M8 Spinal System provide spine surgeons comprehensive solutions for the treatment of spinal deformities, trauma reconstruction, and degenerative conditions....
... The ST360 Spinal Fixation System ... the versatility of lateral connectors into a ... construct that, during assembly, minimizes excessive loading ... for vertebral injury. The combination of polyaxial ...
... Crossover system of implants and instruments provides ... posterior rod construct in the thoracic and ... system are available in three size ranges: ... can be used with the Isola, Pediatric ...
Medicine Products: